<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The microvasculature assumes an inflammatory and procoagulant state in a variety of different diseases, including <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> (SCD), which may contribute to the high incidence of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in these patients </plain></SENT>
<SENT sid="1" pm="."><plain>This study provides evidence for accelerated <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation in arterioles and venules in the cerebral vasculature of mice that express <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>-S (β(s) mice) </plain></SENT>
<SENT sid="2" pm="."><plain>Enhanced microvascular <z:mp ids='MP_0005048'>thrombosis</z:mp> in β(s) mice was blunted by immunologic or genetic interventions that target tissue factor, endothelial protein C receptor, activated protein C, or thrombin </plain></SENT>
<SENT sid="3" pm="."><plain>Platelets from β(s) mice also exhibited enhanced aggregation velocity after stimulation with thrombin but not <z:chebi fb="13" ids="16761">ADP</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001875'>Neutropenia</z:hpo> also protected against the enhanced <z:mp ids='MP_0005048'>thrombosis</z:mp> response in β(s) mice </plain></SENT>
<SENT sid="5" pm="."><plain>These results indicate that the cerebral microvasculature is rendered vulnerable to <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation in β(s) mice via a neutrophil-dependent mechanism that is associated with an increased formation of and enhanced platelet sensitivity to thrombin </plain></SENT>
</text></document>